Evidence map›Paper›PMID 29843955›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2018

MicroRNA-148b Targets the TGF-β Pathway to Regulate Angiogenesis and Endothelial-to-Mesenchymal Transition during Skin Wound Healing.

Vladislav Miscianinov, Andrea Martello, Lorraine Rose, Elisa Parish, Ben Cathcart, Tijana Mitić, Gillian A Gray, Marco Meloni, Ayman Al Haj Zen, Andrea Caporali

Open access · hybridAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 99 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Wound healing and signaling pathways.Open life sciences · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Vladislav MiscianinovUniversity/British Heart Foundation Centre for Cardiovascular Science, QMRI, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Andrea MartelloUniversity/British Heart Foundation Centre for Cardiovascular Science, QMRI, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Lorraine RoseUniversity/British Heart Foundation Centre for Cardiovascular Science, QMRI, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Elisa ParishUniversity/British Heart Foundation Centre for Cardiovascular Science, QMRI, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Ben CathcartUniversity/British Heart Foundation Centre for Cardiovascular Science, QMRI, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Tijana MitićUniversity/British Heart Foundation Centre for Cardiovascular Science, QMRI, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Gillian A GrayUniversity/British Heart Foundation Centre for Cardiovascular Science, QMRI, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Marco MeloniUniversity/British Heart Foundation Centre for Cardiovascular Science, QMRI, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Ayman Al Haj ZenBritish Heart Foundation Centre of Research Excellence, Wellcome Trust Centre for Human Genetics, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
Andrea CaporaliUniversity/British Heart Foundation Centre for Cardiovascular Science, QMRI, University of Edinburgh, Edinburgh EH16 4TJ, UK. Electronic address: a.caporali@ed.ac.uk.
University of Edinburgh · GBBritish Heart Foundation · GBUniversity of Oxford · GB

Funding

ATHEROGENIC &ANTIATHEROGENIC LIPOPROTEINS IN CADF32HL008004 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI WILSON, PAUL R · 1989 to 1990
–
OPIATE/AUTONOMIC INTERACTIONS IN THE CIRCULATORY SYSTEMK04HL001658 · NHLBI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI CAFFREY, JAMES L · 1987 to 1991
–
British Heart Foundation FS/11/52/29018British Heart Foundation FS/14/7/30574British Heart Foundation FS/16/38/32351British Heart Foundation PG/16/58/32275British Heart Foundation RE/08/004/23915
6 · The paper itself

Abstract

Transforming growth factor beta (TGF-β) is crucial for regulation of the endothelial cell (EC) homeostasis. Perturbation of TGF-β signaling leads to pathological conditions in the vasculature, causing cardiovascular disease and fibrotic disorders. The TGF-β pathway is critical in endothelial-to-mesenchymal transition (EndMT), but a gap remains in our understanding of the regulation of TGF-β and related signaling in the endothelium. This study applied a gain- and loss-of function approach and an in vivo model of skin wound healing to demonstrate that miR-148b regulates TGF-β signaling and has a key role in EndMT, targeting TGFB2 and SMAD2. Overexpression of miR-148b increased EC migration, proliferation, and angiogenesis, whereas its inhibition promoted EndMT. Cytokine challenge decreased miR-148b levels in ECs while promoting EndMT through the regulation of SMAD2. Finally, in a mouse model of skin wound healing, delivery of miR-148b mimics promoted wound vascularization and accelerated closure. In contrast, inhibition of miR-148b enhanced EndMT in wounds, resulting in impaired wound closure that was reversed by SMAD2 silencing. Together, these results demonstrate for the first time that miR-148b is a key factor controlling EndMT and vascularization. This opens new avenues for therapeutic application of miR-148b in vascular and tissue repair.

Indexed as

Neovascularization, PhysiologicSignal TransductionWound HealingAnimalsCell MovementDisease Models, AnimalEpithelial-Mesenchymal TransitionFemaleHumansHuman Umbilical Vein Endothelial CellsMiceMicroRNAsSkinSmad2 ProteinTransforming Growth Factor betaTransforming Growth Factor beta2MicroRNAsMIRN148 microRNA, humanSmad2 ProteinSMAD2 protein, humanTGFB2 protein, humanTransforming Growth Factor betaTransforming Growth Factor beta2angiogenesisendothelial-to-mesenchymal transitionmicroRNAsTGF-βwound healing

Identifiers

PMID29843955
PMCPMC6094488
OpenAlexW2801873896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.